Rapamycin Study Could Transform Aging in Older Adults
Large rapamycin clinical trial launches at UT Health San Antonio - UT Health San Antonio
A drug once known almost exclusively for preventing organ transplant rejection is now at the center of a National Institute on Aging-funded clinical study at UT Health San Antonio, to determine how rapamycin should be used in older adults to promote healthy aging.
UT Health San Antonio has launched a major National Institute on Aging-funded clinical trial testing rapamycin, an immunosuppressant drug traditionally used to prevent organ transplant rejection. The study will investigate how rapamycin can promote healthy aging in older adults. This research could unlock new therapeutic applications beyond its current transplant medicine uses.
Original Article
Read full article on sourceExplore More
Related News
Knox Public Health celebrates National Public Health Week
2026.04.05
World Health Day 2026: The Invisible Crisis Could Be Sabotaging Your Health
Free Press Journal · 2026.04.05
Health rules under review
The Star | Malaysia News: National, Regional and World News · 2026.04.05
Opinion: Health care delayed, health care denied
Winnipeg Free Press – Breaking News, Sports, Manitoba, Canada · 2026.04.04
OpenLoop Health has acquired nutrition startup Season Health
2026.04.04
St. Vincent Behavioral Health Campus Expands Housing & Health Care for LA with $6M Health Net Investment
PR Newswire: press release distribution, targeting, monitoring and marketing · 2026.04.04